Literature DB >> 11585313

Clinical and electrophysiological findings in autosomal dominant vitreoretinochoroidopathy: report of a new pedigree.

B A Lafaut1, B Loeys, B P Leroy, W Spileers, J J De Laey, P Kestelyn.   

Abstract

PURPOSE: To report the clinical and electrophysiological findings in a three-generation pedigree with autosomal dominant vitreoretinochoroidopathy.
METHODS: Sixteen members of a three-generation pedigree with autosomal dominant vitreoretinochoroidopathy were examined clinically, including measurement of the corneal diameter. In 14 persons, Goldmann perimetry, axial length determination and electro-oculography were carried out. Electroretinography, according to ISCEV standards, was performed in 11 of 12 affected persons.
RESULTS: Characteristic annular peripheral pigmentary changes were present in all affected members, as well as chorioretinal atrophy varying from a tigroid aspect to marked atrophy. Four patients presented a microcornea and shallow anterior chamber without microphthalmia. The visual fields appeared to narrow with ageing. The electro-oculography was pathological in the affected patients and normal in the unaffected. The electroretinographic amplitude responses tended to worsen with age, with maintenance of near normal latencies.
CONCLUSION: The clinical presentation of autosomal dominant vitreoretinopathy is variable. Electrooculography seems to be a discriminative test. The condition may be associated with anterior segment abnormalities other than presenile cataract, such as microcornea, shallow anterior chamber and angle closure glaucoma.

Entities:  

Mesh:

Year:  2001        PMID: 11585313     DOI: 10.1007/s004170100318

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  9 in total

1.  BEST1-related autosomal dominant vitreoretinochoroidopathy: a degenerative disease with a range of developmental ocular anomalies.

Authors:  A Vincent; C McAlister; C Vandenhoven; E Héon
Journal:  Eye (Lond)       Date:  2010-11-12       Impact factor: 3.775

2.  Alcohol- and light-induced electro-oculographic responses: variability and clinical utility.

Authors:  Michael F Marmor; Kathy H C Wu
Journal:  Doc Ophthalmol       Date:  2005 Mar-May       Impact factor: 2.379

3.  Long-term changes in autosomal dominant vitreoretinochoroidopathy (ADVIRC).

Authors:  L Wöster; J Roider
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-10-03       Impact factor: 3.117

Review 4.  Functional roles of bestrophins in ocular epithelia.

Authors:  Alan D Marmorstein; Harold E Cross; Neal S Peachey
Journal:  Prog Retin Eye Res       Date:  2009-05-04       Impact factor: 21.198

5.  [Hereditary retinochoroidal dystrophies. Part 2: differential diagnosis].

Authors:  U Kellner; A B Renner; H Tillack
Journal:  Ophthalmologe       Date:  2004-04       Impact factor: 1.059

6.  Autosomal dominant Best disease with an unusual electrooculographic light rise and risk of angle-closure glaucoma: a clinical and molecular genetic study.

Authors:  Sancy Low; Alice E Davidson; Graham E Holder; Chris R Hogg; Shomi S Bhattacharya; Graeme C Black; Paul J Foster; Andrew R Webster
Journal:  Mol Vis       Date:  2011-08-23       Impact factor: 2.367

7.  Variable expressivity of BEST1-associated autosomal dominant vitreoretinochoroidopathy (ADVIRC) in a three-generation pedigree.

Authors:  Mariana Matioli da Palma; Maurício E Vargas; Amanda Burr; Rui Chen; Mark E Pennesi; Richard G Weleber; Paul Yang
Journal:  BMJ Open Ophthalmol       Date:  2021-10-21

Review 8.  Nanophthalmos: A Review of the Clinical Spectrum and Genetics.

Authors:  Pedro C Carricondo; Thais Andrade; Lev Prasov; Bernadete M Ayres; Sayoko E Moroi
Journal:  J Ophthalmol       Date:  2018-05-09       Impact factor: 1.909

9.  Ocular Histopathology and Immunohistochemical Analysis in the Oldest Known Individual with Autosomal Dominant Vitreoretinochoroidopathy.

Authors:  Morton F Goldberg; Scott McLeod; Mark Tso; Kirk Packo; Malia Edwards; Imran A Bhutto; Rajkumar Baldeosingh; Charles Eberhart; Bernhard H F Weber; Gerard A Lutty
Journal:  Ophthalmol Retina       Date:  2018-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.